Ticker > Company >

Influx Healthtech share price

Influx Healthtech Ltd.

NSE: INFLUX SECTOR: Pharmaceuticals & Drugs  2   0   0

126.20
0 0
NSE: 25 Jun 4:00 PM

Price Summary

Today's High

₹ 135.85

Today's Low

₹ 125.9

52 Week High

₹ 135.85

52 Week Low

₹ 125.9

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

292.16 Cr.

Enterprise Value

290.47 Cr.

No. of Shares

2.32 Cr.

P/E

21.86

P/B

3.12

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  40.44

CASH

1.91 Cr.

DEBT

0.22 Cr.

Promoter Holding

-

EPS (TTM)

₹  5.77

Sales Growth

0

ROE

ROCE

Profit Growth

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year4.89%
3 Year20.99%
5 YearNA

Profit Growth

1 Year20.11%
3 Year44.43%
5 YearNA

ROE%

1 Year45.37%
3 Year66.44%

ROCE %

1 Year60.15%
3 Year85.75%

Debt/Equity

0.0061

Price to Cash Flow

41.4

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Investors List Share Holding Data is not available for this company.Report us
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 20.9898764565716% for the Past 3 years.
  • The company has significantly decreased its debt by 0.1056 Cr.
  • Company has been maintaining healthy ROE of 66.442% over the past 3 years.
  • Company has been maintaining healthy ROCE of 85.7508333333333% over the past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • The company has a low EBITDA margin of 0% over the past 5 years.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 59.2 76.06 99.97 104.85
Total Expenditure 53.03 65.33 83 84.28
Operating Profit 6.17 10.72 16.96 20.58
Other Income 0 0.01 0.05 0.13
Interest 0.04 0.06 0.22 0.01
Depreciation 0.12 0.94 1.85 2.82
Exceptional Items 0 0 0 0
Profit Before Tax 6.01 9.74 14.93 17.88
Tax 1.57 2.54 3.8 4.51
Net Profit 4.44 7.19 11.13 13.37
Adjusted EPS (Rs.) 2.44 3.96 6.13 7.36

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 0.03 0.03 0.03 18.15
Total Reserves 4.43 11.63 22.75 18
Borrowings 0.08 0.03 0 0
Other N/C liabilities 0.1 0.23 0.05 0.05
Current liabilities 12.96 16.39 17.98 33.92
Total Liabilities 17.59 28.3 40.82 70.12
Assets
Net Block 2.74 6.33 13.73 18.76
Capital WIP 0 0 0 0
Intangible WIP 0 0 0 0
Investments 0 0 0 0
Loans & Advances 0.55 1.15 1.41 1.83
Other N/C Assets 0 0 0 0.5
Current Assets 14.3 20.82 25.68 49.02
Total Assets 17.59 28.3 40.82 70.12
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 6.07 9.74 14.93 17.88
Adjustment 0.13 0.95 2.28 2.81
Changes in Assets & Liabilities -2.01 -1.7 -5.32 -9.2
Tax Paid -1.27 -2.56 -2.95 -4.44
Operating Cash Flow 2.91 6.43 8.94 7.06
Investing Cash Flow -2.86 -4.52 -8.36 -8.64
Financing Cash Flow 1.39 0.18 -0.53 -0.11
Net Cash Flow 1.44 2.08 0.06 -1.7

Corporate Actions

Investors Details

 No Promoters Data available for this company.
Report us
 No Investors Data available for this company.
Report us

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us
Last Updated on:
Brief about Influx Healthtech
X